Ganfeng Xie

2.1k citations
44 papers · 1.6k indexed · 1 hit paper · h-index 22
Topics
Cancer, Hypoxia, and Metabolism (11 papers)Cancer Cells and Metastasis (4 papers)Cell death mechanisms and regulation (4 papers)

In The Last Decade

Ganfeng Xie

43 papers receiving 1.6k citations

Hit Papers

Glutaminase 1 expression in colorectal cancer cells is in...2019202620212023201950100150

Peers

Ganfeng Xie
Comparison fields: 5 of 100
  • Molecular Biology 849
  • Cancer Research 576
  • Oncology 297
  • Biomedical Engineering 277
  • Materials Chemistry 209
Replace Yotaro Izumi with:
Yotaro Izumi United States
Houjie Liang China
Lindsey K. Boroughs United States
Lisha Xiang China
Wantong Yao China
Shoucheng Ning United States
Flonné Wildes United States
Simone Di Franco Italy
Jianping Zhang China
Yun‐Hee Kim South Korea
Ganfeng Xie relative to Yotaro Izumi United States Yotaro Izumi's profile →
Citations per field
00.5×4.6×
Yotaro Izumi · 1×
Citations per year

Countries citing papers authored by Ganfeng Xie

Since Specialization
Citations

This map shows the geographic impact of Ganfeng Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ganfeng Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ganfeng Xie more than expected).

Fields of papers citing papers by Ganfeng Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ganfeng Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ganfeng Xie. The network helps show where Ganfeng Xie may publish in the future.

Co-authorship network of co-authors of Ganfeng Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Ganfeng Xie. A scholar is included among the top collaborators of Ganfeng Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ganfeng Xie. Ganfeng Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 49
3 0
4 4
5 28
6 7
7 10
8 81
9 11
10 1
11 16
12 5
13 6
14 81
15 51
16 23
17 34
18 85
19 31
20 17

About Ganfeng Xie

Ganfeng Xie is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 44 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (11 papers), Cancer Cells and Metastasis (4 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Cancer Research (576 citations), Biochemistry (128 citations) and Molecular Biology (849 citations). Ganfeng Xie has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Houjie Liang, Lisha Xiang, Juanjuan Ou, Jianjun Li, Xing Wei, Jingtao Tong, Songtao Yu, Bin Shao, Hang Shi and Gregg L. Semenza. Their work appears in journals such as Nature Communications, PLoS ONE and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026